Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has provided an update.
Clarity Pharmaceuticals Ltd. has announced a change in substantial holding, indicating that State Street Corporation and its subsidiaries have ceased to be substantial holders in the company as of October 22, 2025. This change in holding may impact the company’s operations and market positioning, as substantial holders can influence corporate governance and strategic decisions.
The most recent analyst rating on (AU:CU6) stock is a Hold with a A$5.00 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 3,467,426
Technical Sentiment Signal: Buy
Current Market Cap: A$1.8B
See more data about CU6 stock on TipRanks’ Stock Analysis page.